Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome.

Durovcová, V; Marek, J; Hána, V; Matoulek, M; Zikán, V; Haluzíková, D; Kaválková, P; Lacinová, Z; Krsek, M; Haluzík, M

Durovcová, V; Marek, J; Hána, V; Matoulek, M; Zikán, V; Haluzíková, D; Kaválková, P; Lacinová, Z; Krsek, M; Haluzík, M.

Affiliation

Durovcová V; Third Department of Medicine, First Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic.

Physiol Res ; 59(3): 415-422, 2010.

Article in En | MEDLINE | ID: mdl-19681655

Subject(s)

Cushing Syndrome/blood; Fibroblast Growth Factors/blood; Obesity/blood; Adiposity; Adult; Biomarkers/blood; Body Mass Index; Case-Control Studies; Cushing Syndrome/physiopathology; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydrocortisone/blood; Male; Middle Aged; Obesity/physiopathology; Waist Circumference

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cushing Syndrome / Fibroblast Growth Factors / Obesity Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Physiol Res Journal subject: FISIOLOGIA Year: 2010 Type: Article Affiliation country: Czech Republic

Search on Google

XML

PubMed Links